Trial intelligence / Profile preview

VMP001/AS01B Vaccine in Healthy Malaria-Naïve Adults

NCT01157897Phase 2Completed

Sponsor
U.S. Army Medical Research and Development Command
Start
Jul 2010
Primary completion
Jan 2012
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of Vivax malaria protein 1 in malaria, sponsored by U.S. Army Medical Research and Development Command. Started Jul 2010; status: completed.

02

Drugs

Vivax malaria protein 1
03

Conditions

malaria

Beyond the preview

Go deeper on NCT01157897.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01157897.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call